FindTrial
Sign In

Clinicopathological and Prognostic Disparities in Part-Solid versus Pure Solid Pulmonary Nodules as Early-Stage Lung Adenocarcinoma

Clinical Study on CT Feature-Based Clinicopathological Disparities and Individualized Surgical Strategy Optimization in Early-Stage Lung Adenocarcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116838
Enrollment
Unknown
Registered
2026-01-15
Start date
2026-01-15
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

PSN group:None
SPN group:None

Sponsors

Shanghai Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Pathologically confirmed as invasive lung adenocarcinoma. 2.Preoperative CT shows peripheral part-solid nodules (PSN) or solid nodules (SPN). 3.Clinical stage is IA (according to the 9th edition of the TNM staging system).

Exclusion criteria

Exclusion criteria: 1.Pure ground-glass nodules (pure GGO). 2.CT examination performed in other hospitals with inconsistent or unavailable image quality. 3.The interval between CT examination and surgery exceeds 1 month. 4.The nodule has an extremely irregular shape and cannot be accurately measured. 5.Non-adenocarcinoma histological types (such as squamous cell carcinoma, small cell lung cancer, etc.). 6.Preoperative neoadjuvant therapy (chemotherapy, radiotherapy, or targeted therapy) was received.

Design outcomes

Primary

MeasureTime frame
5-year recurrence-free survival rate;mCT-solid value;—

Secondary

MeasureTime frame
pathologic grade;viceral pleural invasion;lymph node metastasis;—

Countries

China

Contacts

Public ContactHanyue Li

Shanghai Chest Hospital

hanyue_li@hotmail.com+86 21 2220 0000

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026